Iovance Biotherapeutics (IOVA)'s 30-day implied volatility (IV30) was 93.3% at the close on October 23, 2026, down from 102.3% the day before, against a 52-week range of 55.4% to 138.5%. Its 20-day historical volatility was 86.1%.
Data as of October 23, 2026.